After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than ...

Phase 3 of the Carmel Valley Road and Laureles Garde Roundabout project, originally scheduled to begin Jan. 9, has been moved ...

CARSON CITY, Nev. (KOLO) - On Thursday, Jan. 9, Nevada’s Broadband Equity, Access, and Deployment (BEAD) final proposal was ...

Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...

VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization ...

Persona5: The Phantom X has revealed everything for the latest major content update, as Version 3.0 has been launched today ...

“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...

Doctors at Fortis Hospital successfully performed a rare hybrid cardiac surgery on a 29-year-old man suffering from a ...

Novo Nordisk is my top opportunity for 2026, driven by multiple catalysts and a compelling valuation. The Wegovy pill's FDA ...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has ...

The Punjab government has initiated Phase 2 of its anti-drug campaign, transitioning from law enforcement to community ...

Insider.comNews Commentary - Biopharma M&A is entering a fever pitch, with precision oncology investments alone exploding to $138 billion as major players scramble to secure proven cancer therapies ...